Patients with BMD and XLCM often have sufficient dystrophin expression to display mild skeletal muscle pathology, but BMD has a high risk of heart failure, and XLCM patients succumb to heart failure between 10 and 20 years of age [7,163,164,165,166]. This evidence concerns the gene DMD and heart failure.